Chemical and Structural Aspects of Ebola Virus Entry Inhibitors

ACS Infectious Diseases

Volumn 1, Issue 1, 2015, Pages 42-52

  Nyakatura, Elisabeth K ^a   Frei, Julia C ^a   Lai, Jonathan R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Ebola virus; envelope glycoprotein; viral entry; viral hemhorragic fever

Indexed keywords

ENFUVIRTIDE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS FUSION INHIBITOR; ZMAB; ZMAPP;

CONFORMATIONAL TRANSITION; DRUG STRUCTURE; EBOLAVIRUS; HUMAN; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

EID: 84969217544     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/id500025n     Document Type: Review

References (97)

1. Kuhn, J. H., Bao, Y., Bavari, S., Becker, S., Bradfute, S., Brister, J. R., Bukreyev, A. A., Chandran, K., Davey, R. A., and Dolnik, O. (2013) Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae Arch. Virol. 158 (1) 301-311 10.1007/s00705-012-1454-0
2. Kuhn, J. H., Becker, S., Ebihara, H., Geisbert, T. W., Johnson, K. M., Kawaoka, Y., Lipkin, W. I., Negredo, A. I., Netesov, S. V., and Nichol, S. T. (2010) Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations Arch. Virol. 155 (12) 2083-2103 10.1007/s00705-010-0814-x
3. Feldmann, H. and Geisbert, T. W. (2011) Ebola haemorrhagic fever Lancet 377 (9768) 849-862 10.1016/S0140-6736(10)60667-8
4. Miranda, M. E. G. and Miranda, N. L. J. (2011) Reston ebolavirus in humans and animals in the Philippines: a review J. Infect. Dis. 204 (Suppl. 3) S757-S760 10.1093/infdis/jir296
5. Bale, S., Dias, J. M., Fusco, M. L., Hashiguchi, T., Wong, A. C., Liu, T., Keuhne, A. I., Li, S., Woods, V. L., Jr., and Chandran, K. (2012) Structural basis for differential neutralization of ebolaviruses Viruses 4 (4) 447-470 10.3390/v4040447
6. Dias, J. M., Kuehne, A. I., Abelson, D. M., Bale, S., Wong, A. C., Halfmann, P., Muhammad, M. A., Fusco, M. L., Zak, S. E., Kang, E., Kawaoka, Y., Chandran, K., Dye, J. M., and Saphire, E. O. (2011) A shared structural solution for neutralizing ebolaviruses Nat. Struct. Mol. Biol. 18 (12) 1424-1427 10.1038/nsmb.2150
7. Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., and Saphire, E. O. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Nature 454 (7201) 177-182 10.1038/nature07082
8. Koellhoffer, J. F., Malashkevich, V. N., Harrison, J. S., Toro, R., Bhosle, R. C., Chandran, K., Almo, S. C., and Lai, J. R. (2012) Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation Biochemistry 51 (39) 7665-7675 10.1021/bi300976m
9. Sobarzo, A., Ochayon, D. E., Lutwama, J. J., Balinandi, S., Guttman, O., Marks, R. S., Kuehne, A. I., Dye, J. M., Yavelsky, V., Lewis, E. C., and Lobel, L. (2013) Persistent immune responses after Ebola virus infection New Engl. J. Med. 369 (5) 492-493 10.1056/NEJMc1300266
10. Schnittler, H.-J. and Feldmann, H. (1998) Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin. Infect. Dis. 27 (2) 404-406 10.1086/517704
11. Bray, M. and Geisbert, T. W. (2005) Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever Int. J. Biochem. Cell Biol. 37 (8) 1560-1566 10.1016/j.biocel.2005.02.018
12. Hoenen, T., Groseth, A., Falzarano, D., and Feldmann, H. (2006) Ebola virus: unravelling pathogenesis to combat a deadly disease Trends Mol. Med. 12 (5) 206-215 10.1016/j.molmed.2006.03.006
13. Takada, A. and Kawaoka, Y. (2001) The pathogenesis of Ebola hemorrhagic fever Trends Microbiol. 9 (10) 506-511 10.1016/S0966-842X(01)02201-6
14. Feldmann, H., Volchkov, V. E., Volchkova, V. A., Ströher, U., and Klenk, H.-D. (2001) Biosynthesis and role of filoviral glycoproteins J. Gen. Virol. 82 (12) 2839-2848
15. Mehedi, M., Falzarano, D., Seebach, J., Hu, X., Carpenter, M. S., Schnittler, H.-J., and Feldmann, H. (2011) A new Ebola virus nonstructural glycoprotein expressed through RNA editing J. Virol. 85 (11) 5406-5414 10.1128/JVI.02190-10
16. Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., and Nichol, S. T. (1996) The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing Proc. Natl. Acad. Sci. U.S.A. 93 (8) 3602-3607 10.1073/pnas.93.8.3602
17. Volchkov, V. E., Becker, S., Volchkova, V. A., Ternovoj, V. A., Kotov, A. N., Netesov, S. V., and Klenk, H.-D. (1995) GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and Vaccinia virus polymerases Virology 214 (2) 421-430 10.1006/viro.1995.0052
18. Lee, J. E. and Saphire, E. O. (2009) Ebolavirus glycoprotein structure and mechanism of entry Future Virol. 4 (6) 621-635 10.2217/fvl.09.56
19. Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., and Kawaoka, Y. (1997) A system for functional analysis of Ebola virus glycoprotein Proc. Natl. Acad. Sci. U.S.A. 94 (26) 14764-14769 10.1073/pnas.94.26.14764
20. Jeffers, S. A., Sanders, D. A., and Sanchez, A. (2002) Covalent modifications of the Ebola virus glycoprotein J. Virol. 76 (24) 12463-12472 10.1128/JVI.76.24.12463-12472.2002
21. Sanchez, A., Yang, Z.-Y., Xu, L., Nabel, G. J., Crews, T., and Peters, C. J. (1998) Biochemical analysis of the secreted and virion glycoproteins of Ebola virus J. Virol. 72 (8) 6442-6447
22. Volchkov, V. E., Feldmann, H., Volchkova, V. A., and Klenk, H.-D. (1998) Processing of the Ebola virus glycoprotein by the proprotein convertase furin Proc. Natl. Acad. Sci. U.S.A. 95 (10) 5762-5767 10.1073/pnas.95.10.5762
23. Hunt, C. L., Lennemann, N. J., and Maury, W. (2012) Filovirus entry: a novelty in the viral fusion world Viruses 4 (2) 258-275 10.3390/v4020258
24. Miller, E. H. and Chandran, K. (2012) Filovirus entry into cells-new insights Curr. Opin. Virol. 2 (2) 206-214 10.1016/j.coviro.2012.02.015
25. Hunt, C. L., Kolokoltsov, A. A., Davey, R. A., and Maury, W. (2011) The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus J. Virol. 85 (1) 334-347 10.1128/JVI.01278-09
26. Mulherkar, N., Raaben, M., de la Torre, J. C., Whelan, S. P., and Chandran, K. (2011) The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway Virology 419 (2) 72-83 10.1016/j.virol.2011.08.009
27. Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., and Kawaoka, Y. (2010) Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner PLoS Pathogens 6 (9 e1001121 10.1371/journal.ppat.1001121
28. Saeed, M. F., Kolokoltsov, A. A., Albrecht, T., and Davey, R. A. (2010) Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes PLoS Pathogens 6 (9 e1001110 10.1371/journal.ppat.1001110
29. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., and Delgado, R. (2002) C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans J. Virol. 76 (13) 6841-6844 10.1128/JVI.76.13.6841-6844.2002
30. Ji, X., Olinger, G. G., Aris, S., Chen, Y., Gewurz, H., and Spear, G. T. (2005) Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization J. Gen. Virol. 86 (9) 2535-2542 10.1099/vir.0.81199-0
31. Takada, A., Fujioka, K., Tsuiji, M., Morikawa, A., Higashi, N., Ebihara, H., Kobasa, D., Feldmann, H., Irimura, T., and Kawaoka, Y. (2004) Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry J. Virol. 78 (6) 2943-2947 10.1128/JVI.78.6.2943-2947.2004
32. Shimojima, M., Ikeda, Y., and Kawaoka, Y. (2007) The mechanism of Axl-mediated Ebola virus infection J. Infect. Dis. 196 (Suppl. 2) S259-S263 10.1086/520594
33. Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., Davey, R. A., Hunt, C. L., Moller-Tank, S., Meyerholz, D. K., Rennert, P., Mullins, R. F., and Brindley, M. (2011) T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus Proc. Natl. Acad. Sci. U.S.A. 108 (20) 8426-8431 10.1073/pnas.1019030108
34. Jemielity, S., Wang, J. J., Chan, Y. K., Ahmed, A. A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G. J., and Umetsu, D. T. (2013) TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine PLoS Pathogens 9 (3 e1003232 10.1371/journal.ppat.1003232
35. Moller-Tank, S., Kondratowicz, A. S., Davey, R. A., Rennert, P. D., and Maury, W. (2013) Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry J. Virol. 87 (15) 8327-8341 10.1128/JVI.01025-13
36. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., and Cunningham, J. M. (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection Science 308 (5728) 1643-1645 10.1126/science.1110656
37. Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., and White, J. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein J. Virol. 80 (8) 4174-4178 10.1128/JVI.80.8.4174-4178.2006
38. Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., and White, J. M. (2009) The primed ebolavirus glycoprotein (19-kilodalton GP1, 2): sequence and residues critical for host cell binding J. Virol. 83 (7) 2883-2891 10.1128/JVI.01956-08
39. Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., and Ruthel, G. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Nature 477 (7364) 340-343 10.1038/nature10348
40. Coîté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., and Chandran, K. (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection Nature 477 (7364) 344-348 10.1038/nature10380
41. Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., and Kuehne, A. I. (2012) Ebola virus entry requires the host-programmed recognition of an intracellular receptor EMBO J. 31 (8) 1947-1960 10.1038/emboj.2012.53
42. Harrison, J. S., Higgins, C. D., Chandran, K., and Lai, J. R. (2011) Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects Protein Sci. 20 (9) 1587-1596 10.1002/pro.688
43. Harrison, J. S., Higgins, C. D., O'Meara, M. J., Koellhoffer, J. F., Kuhlman, B. A., and Lai, J. R. (2013) Role of electrostatic repulsion in controlling pH-dependent conformational changes of viral fusion proteins Structure 21 (7) 1085-1096 10.1016/j.str.2013.05.009
44. Harrison, J. S., Koellhoffer, J. F., Chandran, K., and Lai, J. R. (2012) Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle Biochemistry 51 (12) 2515-2525 10.1021/bi3000353
45. Malashkevich, V. N., Schneider, B. J., McNally, M. L., Milhollen, M. A., Pang, J. X., and Kim, P. S. (1999) Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-Ã... resolution Proc. Natl. Acad. Sci. U.S.A. 96 (6) 2662-2667 10.1073/pnas.96.6.2662
46. Weissenhorn, W., Carfí, A., Lee, K.-H., Skehel, J. J., and Wiley, D. C. (1998) Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain Mol. Cell 2 (5) 605-616 10.1016/S1097-2765(00)80159-8
47. Richardson, J. S., Dekker, J. D., Croyle, M. A., and Kobinger, G. P. (2010) Recent advances in Ebolavirus vaccine development Human Vaccines 6 (6) 439-449 10.4161/hv.6.6.11097
48. Saphire, E. O. (2013) An update on the use of antibodies against the filoviruses Immunotherapy 5 (11) 1221-1233 10.2217/imt.13.124
49. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., and Hiatt, E. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp Nature 10.1038/nature13777
50. Olinger, G. G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., Johnson, A. K., and Morton, J. (2012) Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques Proc. Natl. Acad. Sci. U.S.A. 109 (44) 18030-18035 10.1073/pnas.1213709109
51. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N., Kim, D., Pauly, M., Hiatt, A., Ngo, L., Steinkellner, H., and Whaley, K. J. (2011) Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant Proc. Natl. Acad. Sci. U.S.A. 108 (51) 20690-20694 10.1073/pnas.1108360108
52. Qiu, X., Fernando, L., Melito, P. L., Audet, J., Feldmann, H., Kobinger, G., Alimonti, J. B., and Jones, S. M. (2012) Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection PLoS Neglected Trop. Dis. 6 (3 e1575 10.1371/journal.pntd.0001575
53. Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., and Hart, M. K. (2000) Epitopes involved in antibody-mediated protection from Ebola virus Science 287 (5458) 1664-1666 10.1126/science.287.5458.1664
54. Gire, S. K., Goba, A., Andersen, K. G., Sealfon, R. S. G., Park, D. J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., and Dudas, G. (2014) Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak Science 345 (6202) 1369-1372 10.1126/science.1259657
55. Murin, C. D., Fusco, M. L., Bornholdt, Z. A., Qiu, X., Olinger, G. G., Zeitlin, L., Kobinger, G. P., Ward, A. B., and Saphire, E. O. (2014) Structures of protective antibodies reveal sites of vulnerability on Ebola virus Proc. Natl. Acad. Sci. U.S.A. 10.1073/pnas.1414164111
56. Dye, J. M., Herbert, A. S., Kuehne, A. I., Barth, J. F., Muhammad, M. A., Zak, S. E., Ortiz, R. A., Prugar, L. I., and Pratt, W. D. (2012) Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease Proc. Natl. Acad. Sci. U.S.A. 109 (13) 5034-5039 10.1073/pnas.1200409109
57. Chen, G., Koellhoffer, J. F., Zak, S. E., Frei, J. C., Liu, N., Long, H., Ye, W., Nagar, K., Pan, G., and Chandran, K. (2014) Synthetic antibodies with a human framework that protect mice from lethal Sudan Ebolavirus challenge ACS Chem. Biol. 9 (10) 2263-2273 10.1021/cb5006454
58. Oswald, W. B., Geisbert, T. W., Davis, K. J., Geisbert, J. B., Sullivan, N. J., Jahrling, P. B., Parren, P. W. H. I., and Burton, D. R. (2007) Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys PLoS Pathogens 3 (1 e9 10.1371/journal.ppat.0030009
59. Dias, J. o. M., Kuehne, A. I., Abelson, D. M., Bale, S., Wong, A. C., Halfmann, P., Muhammad, M. A., Fusco, M. L., Zak, S. E., and Kang, E. (2011) A shared structural solution for neutralizing ebolaviruses Nat. Struct. Mol. Biol. 18 (12) 1424-1427 10.1038/nsmb.2150
60. Koellhoffer, J. F., Chen, G., Sandesara, R. G., Bale, S., Ollmann Saphire, E., Chandran, K., Sidhu, S. S., and Lai, J. R. (2012) Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein ChemBioChem 13 (17) 2549-2557 10.1002/cbic.201200493
61. Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W. H. I., and Burton, D. R. (1999) Ebola virus can be effectively neutralized by antibody produced in natural human infection J. Virol. 73 (7) 6024-6030
62. Bale, S., Liu, T., Li, S., Wang, Y., Abelson, D., Fusco, M., Woods, V. L., Jr, and Saphire, E. O. (2011) Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion PLoS Neglected Trop. Dis. 5 (11 e1395 10.1371/journal.pntd.0001395
63. Brecher, M., Schornberg, K. L., Delos, S. E., Fusco, M. L., Saphire, E. O., and White, J. M. (2012) Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change J. Virol. 86 (1) 364-372 10.1128/JVI.05708-11
64. Pettitt, J., Zeitlin, L., Kim, D. H., Working, C., Johnson, J. C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., and Johnson, A. K. (2013) Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail Sci. Transl. Med. 5 (199 199ra113 10.1126/scitranslmed.3006608
65. Marzi, A., Wegele, A., and Pöhlmann, S. (2006) Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization Virology 352 (2) 345-356 10.1016/j.virol.2006.04.038
66. Matsuno, K., Nakayama, E., Noyori, O., Marzi, A., Ebihara, H., Irimura, T., Feldmann, H., and Takada, A. (2010) C-type lectins do not act as functional receptors for filovirus entry into cells Biochem. Biophys. Res. Commun. 403 (1) 144-148 10.1016/j.bbrc.2010.10.136
67. He, Y. (2013) Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion Curr. Pharm. Design 19 (10) 1800-1809 10.2174/1381612811319100004
68. Badani, H., Garry, R. F., and Wimley, W. C. (2014) Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity Biochim. Biophys. Acta (BBA)-Biomembranes 1838 (9) 2180-2197 10.1016/j.bbamem.2014.04.015
69. Pessi, A., Langella, A., Capitò, E., Ghezzi, S., Vicenzi, E., Poli, G., Ketas, T., Mathieu, C., Cortese, R., and Horvat, B. (2012) A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity PLoS One 7 (5 e36833 10.1371/journal.pone.0036833
70. Netter, R. C., Amberg, S. M., Balliet, J. W., Biscone, M. J., Vermeulen, A., Earp, L. J., White, J. M., and Bates, P. (2004) Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate J. Virol. 78 (24) 13430-13439 10.1128/JVI.78.24.13430-13439.2004
71. Watanabe, S., Takada, A., Watanabe, T., Ito, H., Kida, H., and Kawaoka, Y. (2000) Functional importance of the coiled-coil of the Ebola virus glycoprotein J. Virol. 74 (21) 10194-10201 10.1128/JVI.74.21.10194-10201.2000
72. Miller, E. H., Harrison, J. S., Radoshitzky, S. R., Higgins, C. D., Chi, X., Dong, L., Kuhn, J. H., Bavari, S., Lai, J. R., and Chandran, K. (2011) Inhibition of Ebola virus entry by a C-peptide targeted to endosomes J. Biol. Chem. 286 (18) 15854-15861 10.1074/jbc.M110.207084
73. Higgins, C. D., Koellhoffer, J. F., Chandran, K., and Lai, J. R. (2013) C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking Bioorg. Med. Chem. Lett. 23 (19) 5356-5360 10.1016/j.bmcl.2013.07.056
74. Clinton, T. R., Weinstock, M. T., Jacobsen, M. T., Szabo-Fresnais, N., Pandya, M. J., Whitby, F. G., Herbert, A. S., Prugar, L. I., McKinnon, R., Hill, C. P., Welch, B. D., Dye, J. M., Eckert, D. M., and Kay, M. S. (2014) Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets Protein Sci. 10.1002/pro.2578
75. Radoshitzky, S. R., Warfield, K. L., Chi, X., Dong, L., Kota, K., Bradfute, S. B., Gearhart, J. D., Retterer, C., Kranzusch, P. J., Misasi, J. N., Hogenbirk, M. A., Wahl-Jensen, V., Volchkov, V. E., Cunningham, J. M., Jahrling, P. B., Aman, M. J., Bavari, S., Farzan, M., and Kuhn, J. H. (2011) Ebolavirus Δ-peptide immunoadhesins inhibit Marburgvirus and Ebolavirus cell entry J. Virol. 85 (17) 8502-8513 10.1128/JVI.02600-10
76. Barrientos, L. G., O'Keefe, B. R., Bray, M., Sanchez, A., Gronenborn, A. M., and Boyd, M. R. (2003) Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus Antiviral Res. 58 (1) 47-56 10.1016/S0166-3542(02)00183-3
77. Dey, B., Lerner, D. L., Lusso, P., Boyd, M. R., Elder, J. H., and Berger, E. A. (2000) Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 Interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses J. Virol. 74 (10) 4562-4569 10.1128/JVI.74.10.4562-4569.2000
78. Helle, F. o., Wychowski, C., Vu-Dac, N., Gustafson, K. R., Voisset, C. c., and Dubuisson, J. (2006) Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans J. Biol. Chem. 281 (35) 25177-25183 10.1074/jbc.M602431200
79. Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., Honnold, S., Bantia, S., Kotian, P., Chen, X., Taubenheim, B. R., Welch, L. S., Minning, D. M., Babu, Y. S., Sheridan, W. P., and Bavari, S. (2014) Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 Nature 508 (7496) 402-405 10.1038/nature13027
80. Shah, P. P., Wang, T., Kaletsky, R. L., Myers, M. C., Purvis, J. E., Jing, H., Huryn, D. M., Greenbaum, D. C., Smith, A. B., Bates, P., and Diamond, S. L. (2010) A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and Ebola pseudotype virus infection into human embryonic kidney 293T cells Mol. Pharmacol. 78 (2) 319-324 10.1124/mol.110.064261
81. Elshabrawy, H. A., Fan, J., Haddad, C. S., Ratia, K., Broder, C. C., Caffrey, M., and Prabhakar, B. S. (2014) Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay J. Virol. 88 (8) 4353-4365 10.1128/JVI.03050-13
82. Misasi, J., Chandran, K., Yang, J.-Y., Considine, B., Filone, C. M., Coîté, M., Sullivan, N., Fabozzi, G., Hensley, L., and Cunningham, J. (2012) Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences J. Virol. 86 (6) 3284-3292 10.1128/JVI.06346-11
83. Marzi, A., Reinheckel, T., and Feldmann, H. (2012) Cathepsin B & L are not required for Ebola virus replication PLoS Neglected Trop. Dis. 6 (12 e1923 10.1371/journal.pntd.0001923
84. Komatsu, K., Inazuki, K., Hosoya, J., and Satoh, S. (1986) Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice Exp. Neurol. 91 (1) 23-29 10.1016/0014-4886(86)90022-1
85. Morimoto, M., Tanabe, F., Kasai, H., and Ito, M. (2007) Effect of a thiol proteinase inhibitor, E-64-d, on susceptibility to infection with Staphylococcus aureus in Chediak-Higashi syndrome (beige) mice Int. Immunopharmacol. 7 (7) 973-980 10.1016/j.intimp.2007.03.004
86. Trinchese, F., Liu, S., Zhang, H., Hidalgo, A., Schmidt, S. D., Yamaguchi, H., Yoshii, N., Mathews, P. M., Nixon, R. A., and Arancio, O. (2008) Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease J. Clin. Invest. 118 (8) 2796-2807 10.1172/JCI34254
87. Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q., Aguilar, H. C., Porotto, M., Honko, A. N., Damoiseaux, R., Miller, J. P., Woodson, S. E., Chantasirivisal, S., Fontanes, V., Negrete, O. A., Krogstad, P., Dasgupta, A., Moscona, A., Hensley, L. E., Whelan, S. P., Faull, K. F., Holbrook, M. R., Jung, M. E., and Lee, B. (2010) A broad-spectrum antiviral targeting entry of enveloped viruses Proc. Natl. Acad. Sci. U.S.A. 107 (7) 3157-3162 10.1073/pnas.0909587107
88. Wilson, A. J. (2009) Inhibition of protein-protein interactions using designed molecules Chem. Soc. Rev. 38 (12) 3289-3300 10.1039/b807197g
89. Lee, K., Ren, T., Coîté, M., Gholamreza, B., Misasi, J., Bruchez, A., and Cunningham, J. (2013) Inhibition of Ebola virus infection: identification of Niemann-Pick C1 as the target by optimization of a chemical probe ACS Med. Chem. Lett. 4 (2) 239-243 10.1021/ml300370k
90. Basu, A., Li, B., Mills, D. M., Panchal, R. G., Cardinale, S. C., Butler, M. M., Peet, N. P., Majgier-Baranowska, H., Williams, J. D., and Patel, I. (2011) Identification of a small-molecule entry inhibitor for filoviruses J. Virol. 85 (7) 3106-3119 10.1128/JVI.01456-10
91. Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., and Scully, C. (2013) FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection Sci. Transl. Med. 5 (190 190ra79 10.1126/scitranslmed.3005471
92. Shoemaker, C. J., Schornberg, K. L., Delos, S. E., Scully, C., Pajouhesh, H., Olinger, G. G., Johansen, L. M., and White, J. M. (2013) Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection PLoS One 8 (2 e56265 10.1371/journal.pone.0056265
93. Gehring, G., Rohrmann, K., Atenchong, N., Mittler, E., Becker, S., Dahlmann, F., Pöhlmann, S., Vondran, F. W. R., David, S., and Manns, M. P. (2014) The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry J. Antimicrob. Chemother. dku091 10.1093/jac/dku091
94. Yermolina, M. V., Wang, J., Caffrey, M., Rong, L. L., and Wardrop, D. J. (2011) Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry J. Med. Chem. 54 (3) 765-781 10.1021/jm1008715
95. Mire, C. E., Geisbert, J. B., Marzi, A., Agans, K. N., Feldmann, H., and Geisbert, T. W. (2013) Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus PLoS Neglected Trop. Dis. 7 (12 e2600 10.1371/journal.pntd.0002600
96. Gavrilyuk, J., Uehara, H., Otsubo, N., Hessell, A., Burton, D. R., and Barbas, C. F. (2010) Potent inhibition of HIV-1 entry with a chemically programmed antibody aided by an efficient organocatalytic synthesis ChemBioChem 11 (15) 2113-2118 10.1002/cbic.201000432
97. Gavrilyuk, J., Ban, H., Uehara, H., Sirk, S. J., Saye-Francisco, K., Cuevas, A., Zablowsky, E., Oza, A., Seaman, M. S., Burton, D. R., and Barbas, C. F. (2013) Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG J. Virol. 87 (9) 4985-4993 10.1128/JVI.03146-12